Our team at SOPHiA GENETICS continues to work to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS and developed a robust solution for full-genome analysis of SARS-CoV-2 to identify circulating and emerging strains. Recently, our genomic experts have worked with international partners …
Fraudsters vs. Banks – who is winning the battle in Australia? Banks that educate their customers about fraud and use AI-driven software will build loyalty and value, write Navinesh Chand, Arif … READ MORE
01.06.2021 We regret to announce that due to severe technical issues with the virtual platform that were brought to our attention only this week, the ESHG Executive Board has been forced to postpone the conference to August 28-31, 2021. This decision was not taken lightly, but in order to avoid disappointment for delegates, presenters and sponsors alike, and to …
ESHG 2021 – Virtual Conference Postponed! August 28-31, 2021 Read More »
About Hereditary cancer syndromes are a set of complex diseases, often presenting with diverse clinical phenotypes, involving multiple genes of interest with variable penetrance. Large scale genomic sequencing of multi-gene panels has become the standard of care. However, READ MORE
THE PATHOLOGY UPDATE 2021 WEBSITE CONTENT WILL BE UPDATED AS ADDITIONAL INFORMATION BECOMES AVAILABLE. PLEASE CHECK BACK HERE REGULARLY FOR UPDATES. Welcome to Pathology Update 2021: Re: Cracking the Code It is with great pleasure and heartfelt thanks that the College welcomes you to Pathology Update 2021. After the hiatus of 2020 it is especially …
PATHOLOGY UPDATE 2021 EARLY BIRD REGISTRATION CLOSES: FRIDAY 18 JUNE 2021 Read More »
More than six people die every hour in the US from a blood cancer. Solutions can’t come fast enough for those who suffer with these cancers all around the world. Fortunately, researchers studying blood diseases have experienced rapid advances in their capabilities to develop and test effective therapies with some extremely significant advancements. READ MORE
Two different companies, cardiac fibrosis RNA company HAYA Therapeutics and COVID-19 bispecific player RenBio, launched today with funding rounds designed to push them toward the clinic. New York-based RenBio announced a $24 million series A round, led by Ruentex Group, to move its lead bispecific antibody into phase 1/2 trials by the end of the year. The …
The new Welink identity represents the changes our organisation is undergoing as well as an important shift in our values and our reach. Although our mission and vision remain the same, Welink is now the name of an umbrella company that has under its wing 6 different platforms, each offering services in 8 different countries …
Welink: Breaking new ground with a new visual identity Read More »
NetGuardians is recognized as a “Category Leader” in Chartis’ latest report – Financial Crime Risk Management Systems: Enterprise Fraud; Market Update and Vendor Landscape, 2021 This is the third consecutive time NetGuardians is selected as one of the top vendors in Chartis’ Enterprise Fraud Report Quadrant. READ MORE
NETGUARDIANS AND PWC SINGAPORE PARTNER TO HELP BANKS FIGHT FRAUD Yverdon-les-Bains, 25 February 2021: Award-winning Swiss FinTech NetGuardians, renowned for its smarter AI-based, enterprise risk platform for combating banking fraud, today announces a partnership with PwC Singapore to fight fraud. The move comes as banks are increasingly offering innovative digital services to meet the needs of …